Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 39,000 shares, a decline of 42.8% from the May 31st total of 68,200 shares. Based on an average daily trading volume, of 483,000 shares, […]